MARKET WIRE NEWS
  1. Home
  2. Stock
  3. REGN
  4. Message Board
  5. Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Read Post Read Post 618436 - Regeneron ($REGN) Dupixent Phase 4 Trial Results Show
REGN
Quote
Short
News
Articles
Message Board

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN Message Board Post 618436

Recent REGN Posts
Posted By: (investorshub) @iHub News

Posted on: May/05/2026 14:31:22

Regeneron ($REGN) Dupixent Phase 4 Trial Results Show

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177571562

Back to REGN Board

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Message Board Posts

Recent REGN Posts
investorshub : jgrabar
On May 15, 2026, Regeneron issued a press
investorshub : iHub News
Regeneron slides after melanoma study misses key endpoint
investorshub : iHub News
Regeneron Tops Q1 Estimates on Dupixent Momentum April
investorshub : iHub News
Markets Steady Ahead of Fed Decision and Key

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.